Phase 4 Tuberculosis Trial, Recruiting NCT07213765 Sponsor: Bin Cao Condition: Tuberculosis
Back to Tuberculosis

Phase 4 Tuberculosis Trial, Recruiting

NCT07213765
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing to take part in the study and agree to sign a consent form.
  • You are between 18 and 75 years old (any gender).
  • You have been diagnosed with a specific type of lung disease caused by a bacteria called MAC (Mycobacterium avium complex), confirmed using established medical guidelines, with a particular pattern seen on lung scans (confirm with trial site).
  • You have not received any treatment for MAC in the 3 months before joining the study.
  • If you are a woman who could become pregnant and have not had surgery to prevent pregnancy, you must use an accepted form of birth control during the study and for 3 months after your last dose, test negative for pregnancy within 72 hours before joining, and not be breastfeeding.
  • If you are a man whose partner could become pregnant, you must use effective birth control during the study and for 3 months after your last dose.
  • Your blood, liver, kidney, and heart function must meet certain minimum health levels, checked within one week before joining (confirm specific values with trial site).
  • If you have diabetes, your blood sugar must be stable and well controlled.

Who may not be able to join:

  • You have had an allergic reaction to any of the medicines used in this study.
  • You have a lung infection caused by more than one type of bacteria, fungus, or virus at the same time, including HIV.
  • You have a condition that weakens your immune system, an active lung cancer, or another cancer that currently requires chemotherapy or radiation treatment.
  • You have previously had a solid organ transplant (such as a kidney, liver, or heart transplant).
  • You are currently on dialysis for kidney failure.
  • You have certain serious lung conditions, such as uncontrolled radiation-related lung inflammation, active scarring of the lungs, or significant fluid buildup around your lungs or heart that is not controlled (confirm with trial site).
  • You have certain serious or unstable health conditions, including very high blood pressure that is out of control, severe heart failure, a heart attack in the past 6 months, severe mental health conditions requiring medication, severe liver or kidney disease, or a neurodegenerative disease such as Alzheimer's disease.
  • You have significant problems with your digestive system that affect how your body absorbs food or medicine.
  • You have taken part in another clinical drug trial within the 4 weeks before starting this study.
  • You are currently taking part in another interventional clinical trial (a study testing a treatment), unless it is an observation-only study or the follow-up stage of a study that has already finished.
  • You have any other health findings that the study doctor believes could affect the study results or increase your risk of complications during treatment (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Xiaojin Cui, M.D., China-Japan Friendship Hospital

Phone: +861084205566

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Bin Cao
Registry
ClinicalTrials.gov
Start date
24 July 2025
Est. completion
30 September 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

culture conversion; CT lesion absorption; QOL-B+NTM module

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov